Now in our 30th year! Now in our 30th year of advancing the science of learning and behavior change.
PRIME, a healthcare education and research company, offers continuing professional development for the interprofessional team while identifying and solving problems within health systems to facilitate optimal patient care. Leading the industry with 50 peer-reviewed publications in the last 2 years
06/23/2026
New Release! | Accelerating Evidence into Practice: Latest Guidelines and Clinical Evidence for Bispecific Antibodies in R/R DLBCL and FL | 0.25-hour CME/CE | On-Demand Video Podcast #1 of 5 Enduring from ASH 2025 Meeting | | https://bit.ly/3QvmQCr
06/23/2026
MDR-HIV Video Podcast | Contemporary Antiretroviral Therapies for Managing Multidrug-Resistant HIV | 0.25-hour CME/CE | Watch or Listen in Today | | https://bit.ly/4dL8PtB
06/23/2026
Last Chance to Register!
Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care | 0.5-hour CME/CE |
| https://bit.ly/44mkFVA
06/23/2026
HER2 Podcast #1 of 2 | From Testing to Treatment: Navigating HER2 Testing and Clinical Evidence Across Solid Tumors | 0.5-hour CME/CE | Recorded Live at USCAP 2026 | | https://bit.ly/42Bz4wk
06/22/2026
PWS Learning Pathway | Prader-Willi Syndrome in Practice: From Recognition to Targeted Therapy | 0.25-hour CME/CE | Experience our Interactive Clinical Decision Making Simulation Today! | https://bit.ly/42ecEAU
Live Event, July 31st!
Bridging Evidence and Practice: Closing the Gap to Achieve LDL-C Targets and Reduce ASCVD Risk | 1.5-hour CME/CE | Satellite Symposium from the 2026 ASPC Congress on CVD Prevention | | Register Here: https://primeinc.org/72LV253?utm_campaign=72LV253&utm_source=prime&utm_medium=socpd2&hr=prime
06/22/2026
Hot Topics in Myelofibrosis Management: Navigating Current Treatment Paradigms With JAK Inhibitors | 0.5-hour CME/CE | On-Demand Video Podcast #1 of 4, MF Sympo at ASH 2025 | Don't Miss Out!
| https://bit.ly/4c3Fj1C
06/22/2026
Watch Today! | Accelerating Evidence into Practice: Considerations for Individualized bsAb Therapy in R/R DLBCL and FL | 0.5-hour CME/CE | On-Demand Video Podcast #4 of 5 Enduring from ASH 2025 Meeting | | https://bit.ly/3OySjmG
06/21/2026
Hot Topics in Myelofibrosis Management: Aiming for Improved Outcomes and Disease Modification | 0.5-hour CME/CE | On-Demand Video Podcast #4 of 4, MF Symposium at ASH 2025 | | https://bit.ly/3PWHf3i
06/21/2026
Watch Now! | Clinical Momentum: Advancements for Menin Inhibitors in NPM1-Mutated AML | 0.5-hour CME/CE | On-Demand Video Podcast #3 of 4, AML Symposium at ASH 2025 | | https://bit.ly/4cA85qz